跳转至内容
Merck
CN
  • In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane.

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane.

Melanoma research (2014-06-04)
Suzan Commandeur, Sarah J Sparks, Hee-Lam Chan, Linda Gao, Jacoba J Out, Nelleke A Gruis, Remco van Doorn, Abdoelwaheb El Ghalbzouri
摘要

A critical first step in the metastatic progression of cutaneous melanoma, invasive growth into the dermal compartment, would ideally be studied in the proper three-dimensional tissue microenvironment. In this study, we compared the growth and behavior of four melanoma cell lines originating from primary and metastatic human cutaneous melanomas (AN, RU, M14, and WK) in in-vitro human skin equivalents (HSEs) generated with four different dermal matrices: human fibroblast-seeded rat tail collagen, human fibroblast-derived matrix (FDM), noncellular human de-epidermized dermis (DED), and a novel fully cellular human DED with an intact pre-existent basement membrane. Melanoma cells showed proliferation in all HSEs, indicating that the microenvironment formed in all HSEs studied here allows the growth of melanoma cells in concert with epidermal keratinocytes for multiple weeks in vitro. Melanoma cells did not affect epidermal proliferation and terminal differentiation. Growth of melanoma cells in the dermal compartment, as a measure of invasive potential, differs markedly between the four types of in-vitro human melanoma models. Notably, the growth of melanoma cells in the dermal matrix was observed in all HSEs cultured with cell lines originating from metastatic melanoma, except for cDED-based HSEs, and the growth of melanoma cells of nonmetastatic origin was observed in the dermal compartment of FDM-based HSEs. Our results show that the type of dermal equivalent and the presence of an intact basement membrane should be taken into consideration when studying melanoma invasion using in-vitro HSEs.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
乙酸, glacial, ACS reagent, ≥99.7%
Sigma-Aldrich
乙酸, glacial, ReagentPlus®, ≥99%
Sigma-Aldrich
乙酸, glacial, ≥99.99% trace metals basis
Sigma-Aldrich
乙酸 溶液, suitable for HPLC
Sigma-Aldrich
乙酸, glacial, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8%
Sigma-Aldrich
乙酸, glacial, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.8-100.5%
Sigma-Aldrich
棕榈酸, ≥99%
Sigma-Aldrich
α-Linoleic acid, ≥98%
Sigma-Aldrich
L-丝氨酸, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
L-丝氨酸, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
亚油酸, liquid, BioReagent, suitable for cell culture
Sigma-Aldrich
棕榈酸, BioXtra, ≥99%
Sigma-Aldrich
花生四烯酸, >95.0% (GC)
Sigma-Aldrich
乙酸, suitable for luminescence, BioUltra, ≥99.5% (GC)
USP
冰醋酸, United States Pharmacopeia (USP) Reference Standard
Supelco
棕榈酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
花生四烯酸, from non-animal source, ≥98.5% (GC)
Sigma-Aldrich
亚硒酸, 98%
Sigma-Aldrich
L -肉碱 内盐, synthetic, ≥98%
Supelco
乙酸, analytical standard
Sigma-Aldrich
棕榈酸, ≥98%, FCC, FG
Sigma-Aldrich
乙酸, ≥99.5%, FCC, FG
Sigma-Aldrich
乙酸, natural, ≥99.5%, FG
USP
棕榈酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
亚油酸, technical, 58-74% (GC)
Supelco
亚油酸, analytical standard
Supelco
棕榈酸, analytical standard
Sigma-Aldrich
乙酸, glacial, puriss., 99-100%
Sigma-Aldrich
L-丝氨酸, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
棕榈酸, ≥98% palmitic acid basis (GC)